Piramal Pharma surges despite reporting 75% fall in Q4 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Piramal Pharma is currently trading at Rs. 80.20, up by 6.14 points or 8.29% from its previous closing of Rs. 74.06 on the BSE.
The scrip opened at Rs. 76.80 and has touched a high and low of Rs. 83.90 and Rs. 76.80 respectively. So far 2417160 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 201.80 on 19-Oct-2022 and a 52 week low of Rs. 63.13 on 28-Mar-2023.
Last one week high and low of the scrip stood at Rs. 83.90 and Rs. 71.56 respectively. The current market cap of the company is Rs. 9619.34 crore.
The promoters holding in the company stood at 34.79%, while Institutions and Non-Institutions held 44.25% and 20.96% respectively.
Piramal Pharma has reported results for fourth quarter (Q4) and year ended March 31, 2023.
The company has reported 72.46% fall in its net profit at Rs 41.70 crore for the quarter under review as compared to Rs 151.44 crore for the same quarter in the previous year. Total income of the company decreased by 7.06% at Rs 1,117.46 crore for Q4FY23 as compared to Rs 1,202.38 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 75.44% fall in its net profit at Rs 50.11 crore for fourth quarter ended March 31, 2023 as compared to Rs 204.06 crore for the same quarter in the previous year. Total income of the company decreased by 0.97% at Rs 2,188.08 crore for Q4FY23 as compared to Rs 2,209.50 crore for the corresponding quarter previous year.
For the year ended March 31, 2023, the company has reported 81.09% fall in its net profit at Rs 69.50 crore as compared to Rs 367.54 crore for the previous year. However, total income of the company increased by 6.14% at Rs 3784.29 crore for year under review as compared to Rs 3,565.21 crore for year ended March 31, 2022.
For the year ended March 31, 2023, on the consolidated basis, the company has reported net loss of Rs 186.46 crore as compared to net profit of Rs 375.96 crore for the previous year. However, total income of the company increased by 6.90% at Rs 7,306.66 crore for year under review as compared to Rs 6,834.90 crore for year ended March 31, 2022.
